Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOLERATE gastrointestinal tolerability study of Tecfidera in relapsing-remitting multiple sclerosis
2013-001486-17Phase 4Completed
- Sponsor
- Biogen
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dimethyl fumarate in multiple sclerosis (MS), sponsored by Biogen. Primary endpoint: Frequency, severity, and duration of gastrointestinal-related events with symptomatic therapy use. Started Mar 2014; status: completed.
02
Drugs
dimethyl fumarate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2013-001486-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001486-17.